We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $7.22B
1-Year Est. Return 110.75%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+110.75%
3 Year Est. Return
+393.62%
5 Year Est. Return
+449.87%
10 Year Est. Return
+5,767.79%
AUM
$2.63B
AUM Growth
+$589M
Cap. Flow
-$474M
Cap. Flow %
-18.01%
Top 10 Hldgs %
88.03%
Holding
19
New
5
Increased
2
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
CAR icon
Avis
CAR
+$79.9M
2
DXC icon
DXC Technology
DXC
+$67.1M
3
P
Pandora Media Inc
P
+$53M
4
TWTR
Twitter, Inc.
TWTR
+$34.1M
5
ALLY icon
Ally Financial
ALLY
+$3.14M

Top Sells

Rank Stock Value
1
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$286M
2
X
US Steel
X
+$105M
3
DXCM icon
DexCom
DXCM
+$94.9M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$55.3M
5
ANDV
Andeavor
ANDV
+$53.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.94%
2 Communication Services 19.88%
3 Consumer Discretionary 10.03%
4 Healthcare 9.67%
5 Financials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
CALL
Invesco QQQ Trust
QQQ
$474B
$551M 20.91%
+4,000,000
New +$550M
SPY icon
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$423M 16.07%
+1,750,000
New +$419M
TWTR
3
DELISTED
Twitter, Inc.
TWTR
$271M 10.28%
15,140,000
+2,000,000
+15% +$34.1M
ALLY icon
4
Ally Financial
ALLY
$12.5B
$221M 8.4%
10,580,000
+160,000
+2% +$3.14M
CHTR icon
5
Charter Communications
CHTR
$16.8B
$204M 7.74%
605,000
-145,000
-19% -$48.4M
PODD icon
6
Insulet
PODD
$9.64B
$143M 5.45%
2,795,000
-55,000
-2% -$2.39M
TIF
7
DELISTED
Tiffany & Co.
TIF
$142M 5.4%
1,515,000
-145,000
-9% -$13.3M
GDX icon
8
VanEck Gold Miners ETF
GDX
$28.2B
$131M 4.96%
5,920,000
-1,725,000
-23% -$39.2M
AAP icon
9
Advance Auto Parts
AAP
$2.66B
$122M 4.63%
1,045,000
-45,000
-4% -$6.18M
ANDV
10
DELISTED
Andeavor
ANDV
$110M 4.19%
1,180,000
-635,000
-35% -$53.6M
ALNY icon
11
Alnylam Pharmaceuticals
ALNY
$32.5B
$90.5M 3.44%
1,135,000
-865,000
-43% -$55.3M
CAR icon
12
Avis
CAR
$4.24B
$84.5M 3.21%
+3,100,000
New +$79.9M
DXC icon
13
DXC Technology
DXC
$1.94B
$67.1M 2.55%
+1,011,500
New +$67.1M
P
14
DELISTED
Pandora Media Inc
P
$49.1M 1.87%
+5,505,000
New +$53M
MDCO
15
DELISTED
Medicines Co
MDCO
$20.7M 0.79%
545,000
-135,000
-20% -$6.01M
ATCO
16
DELISTED
Atlas Corp.
ATCO
$3.21M 0.12%
450,000
-110,000
-20% -$684K
DXCM icon
17
DexCom
DXCM
$32.9B
– –
-4,478,000
Closed -$94.9M
X
18
DELISTED
US Steel
X
– –
-3,115,000
Closed -$105M
XLF icon
19
State Street Financial Select Sector SPDR ETF
XLF
$54.2B
– –
-12,060,000
Closed -$286M

Similar funds

GT
Glenview Trust Louisville, Kentucky $7.23B AUM 27.68% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $7.25B AUM 33.76% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $7.18B AUM 18.15% 1-Year Est. Return
TB
Thoma Bravo Chicago, Illinois $7.28B AUM 35.55% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return

Slate Path Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Slate Path Capital held 19 positions worth $2.63B, up 29% from $2.04B the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Slate Path Capital withdrew a net $474M in Q2 2017, closing 3 positions and reducing 9 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $286M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 23% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Slate Path Capital opened a new position in Avis worth $84.5M.

  • Slate Path Capital's largest Q2 2017 buy was Avis: 3,100,000 shares worth $84.5M.
  • Slate Path Capital added most to Twitter, Inc. in Q2 2017, an estimated $34.1M increase.
  • Slate Path Capital's biggest Q2 2017 reduction was Alnylam Pharmaceuticals, cutting an estimated $55.3M.
  • Slate Path Capital fully exited State Street Financial Select Sector SPDR ETF in Q2 2017, selling an estimated $286M.
  • Slate Path Capital's ten largest holdings make up 88% of its $2.63B portfolio in Q2 2017.
  • Slate Path Capital opened 5 new positions and closed 3 in Q2 2017.
  • Slate Path Capital's portfolio value rose 29% quarter-over-quarter to $2.63B.

Based on Slate Path Capital's 13F filing for Q2 2017, filed 14 Aug 2017.